Becton Dickinson ROA 2010-2022 | BDX

Current and historical return on assets (ROA) values for Becton Dickinson (BDX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Becton Dickinson ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2022-06-30 $1.67B $53.20B 3.10%
2022-03-31 $1.83B $54.79B 3.38%
2021-12-31 $1.68B $53.36B 3.10%
2021-09-30 $2.00B $53.87B 3.68%
2021-06-30 $1.87B $54.33B 3.42%
2021-03-31 $1.64B $54.92B 3.01%
2020-12-31 $1.51B $54.75B 2.79%
2020-09-30 $0.77B $54.01B 1.44%
2020-06-30 $0.79B $53.96B 1.49%
2020-03-31 $0.92B $53.52B 1.76%
2019-12-31 $0.76B $51.95B 1.46%
2019-09-30 $1.08B $51.77B 2.07%
2019-06-30 $0.78B $52.23B 1.48%
2019-03-31 $0.93B $52.60B 1.74%
2018-12-31 $0.90B $52.93B 1.66%
2018-09-30 $0.16B $53.90B 0.29%
2018-06-30 $0.62B $53.98B 1.23%
2018-03-31 $-0.10B $54.57B -0.22%
2017-12-31 $0.29B $55.36B 0.76%
2017-09-30 $1.03B $37.73B 3.34%
2017-06-30 $0.76B $37.17B 2.73%
2017-03-31 $1.32B $24.12B 5.26%
2016-12-31 $1.31B $24.32B 5.13%
2016-09-30 $0.98B $25.59B 3.76%
2016-06-30 $1.14B $26.02B 4.34%
2016-03-31 $0.81B $26.24B 3.06%
2015-12-31 $0.69B $26.05B 2.55%
2015-09-30 $0.70B $26.48B 2.77%
2015-06-30 $0.82B $27.08B 3.78%
2015-03-31 $1.08B $28.29B 6.03%
2014-12-31 $1.15B $18.50B 8.28%
2014-09-30 $1.19B $12.45B 9.65%
2014-06-30 $0.97B $12.37B 7.98%
2014-03-31 $0.95B $12.25B 7.91%
2013-12-31 $0.94B $12.04B 7.92%
2013-09-30 $1.29B $12.15B 11.01%
2013-06-30 $1.49B $11.59B 12.92%
2013-03-31 $1.52B $11.63B 13.29%
2012-12-31 $1.53B $11.63B 13.55%
2012-09-30 $1.17B $11.36B 10.40%
2012-06-30 $1.18B $11.03B 10.72%
2012-03-31 $1.20B $11.20B 10.97%
2011-12-31 $1.22B $11.41B 11.38%
2011-09-30 $1.27B $10.43B 12.26%
2011-06-30 $1.37B $10.62B 13.45%
2011-03-31 $1.33B $10.34B 13.63%
2010-12-31 $1.32B $10.07B 13.99%
2010-09-30 $1.32B $9.65B 14.36%
2010-06-30 $1.24B $9.03B 13.61%
2010-03-31 $1.27B $8.94B 14.06%
2009-12-31 $1.24B $9.09B 14.19%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $76.093B $20.248B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $53.389B 15.50
AmerisourceBergen (ABC) United States $31.591B 13.95
West Pharmaceutical Services (WST) United States $25.237B 38.42
Laboratory Of America Holdings (LH) United States $24.116B 10.55
Cardinal Health (CAH) United States $19.062B 13.83
Cooper (COO) United States $16.446B 25.31
CONMED (CNMD) United States $3.144B 30.99
Invacare (IVC) United States $0.035B 0.00